Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum Borja Quiroga , María José Soler , Maria Dolores Sanchez-Niño , Esther Orero , Sandra Tejedor , Carlos Jesús Jarava Mantecón , Virginia Olinda Gómez Pérez , Antonio José Marín Franco , Christian Alfaro Sánchez , Marta Puerta Carretero , María Teresa Jaldo Rodríguez , Manuel Antonio Carnerero Di Riso , Shaira Martínez , Carmen Calderón González , Michal Cervienka , Nicolás Macías Carmona , David Arroyo , Katia M Pérez Del Valle , Gabriel de Arriba , Auxiliadora Mazuecos , Juan Manuel Cazorla , Mónica Pereira , Emilio González Parra , María Gabriela Sánchez Márquez , Carolina Lancho Novillo , Carmen Toyos Ruiz , María Cinta Aguilar Cervera , Patricia Muñoz Ramos , Ana Sánchez Horrillo , Isabel Jimeno Martín , Néstor Toapanta , Secundino Cigarrán Guldris , Montserrat Folgueiras López , Rosalía Valero San Cecilio , Blanca Villacorta Linaza , Ignacio Minguela Pesquera , Raquel Santana Estupiñán , Rocío Zamora , Sagrario Soriano , Eduardo Muñoz de Bustillo , María Soledad Pizarro Sánchez , Ana Isabel Martínez Puerto , Alejandra Yugueros , Laura Muñiz Pacios , Alba Leyva , José Rojas , Ron T Gansevoort , Patricia de Sequera CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY（2022）
摘要
Information on the effect of a third dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in advanced CKD is incomplete ([1][1]). We assessed the humoral response up to 6 months after receipt of two or three doses of the SARS-CoV-2 vaccine across the CKD spectrum. SENCOVAC is
更多 查看译文
关键词
COVID-19, vaccination, anti-Spike, chronic kidney disease, hemodialysis, peritoneal dialysis, kidney transplantation, SARS-CoV-2
AI 理解论文
溯源树
样例
